These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 140180)

  • 41. The dopaminergic regulation of plasma growth hormone secretion in normal subjects.
    Hanew K; Sato S; Sasaki A; Goh M; Shimizu Y; Yoshinaga K
    Tohoku J Exp Med; 1986 Feb; 148(2):151-8. PubMed ID: 3961796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The endocrinology of extrapyramidal system disorders.
    Kirkpatrick B; Tamminga CA
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):159-72. PubMed ID: 2967753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of gamma-aminobutyric acid on growth hormone and prolactin secretion in man: influence of pimozide and domperidone.
    Cavagnini F; Benetti G; Invitti C; Ramella G; Pinto M; Lazza M; Dubini A; Marelli A; Müller EE
    J Clin Endocrinol Metab; 1980 Oct; 51(4):789-92. PubMed ID: 7419665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of bromocriptine and dopamine on pituitary hormone secretion in women].
    Masaoka K; Hosoya N; Mori T; Watanabe H; Ohkura T; Kumasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2155-62. PubMed ID: 6818310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression of prolactin and growth hormone responses to 2-deoxy-D-glucose-induced glucoprivation by mazindol in humans.
    Thompson DA; Lilavivat U; Campbell RG
    Metabolism; 1981 Oct; 30(10):1015-20. PubMed ID: 7278648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroendocrine studies in dementia patients: responses of plasma GH and PRL following bromocriptine administration.
    Higashi S; Fujita M; Nishimoto Y; Kuroda K; Asaba H; Sakai T
    Acta Neurol Scand; 1994 Jul; 90(1):39-44. PubMed ID: 7941955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles.
    Hickey G; Jacks T; Judith F; Taylor J; Schoen WR; Krupa D; Cunningham P; Clark J; Smith RG
    Endocrinology; 1994 Feb; 134(2):695-701. PubMed ID: 8299565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
    Sklar CA; Rothenberg S; Blumberg D; Oberfield SE; Levine LS; David R
    J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of Huntington's chorea with bromocriptine.
    Frattola L; Albiazzati MG; Spano PF; Trabucchi M
    Acta Neurol Scand; 1977 Jul; 56(1):37-45. PubMed ID: 141860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolactin and growth hormone responses to psychological stress in normal and neurotic subjects.
    Miyabo S; Asato T; Mizushima N
    J Clin Endocrinol Metab; 1977 May; 44(5):947-51. PubMed ID: 870518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects.
    Camanni F; Massara F; Fassio V; Molinatti GM; Müller EE
    Neuroendocrinology; 1975; 19(3):227-40. PubMed ID: 1223659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variation of blood glucose and serum growth hormone, prolactin and insulin in subjects with insulin-dependent diabetes, after OGTT and pretreatment with 2-Br-alpha-ergocryptine.
    Gnudi A; Lugari R; Cavazzini MG
    Acta Diabetol Lat; 1977; 14(3-4):119-28. PubMed ID: 343464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired prolactin release in Huntington's chorea. Evidence for dopaminergic excess.
    Hayden MR; Vinik AI; Paul M; Beighton P
    Lancet; 1977 Aug; 2(8035):423-6. PubMed ID: 70642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroendocrinologic findings in patients with untreated Huntington's chorea.
    Caraceni TA; Parati EA; Giovannini PM; Grassi MP; Scigliano G; Carella F; Müller EE
    Arch Neurol; 1984 May; 41(5):516-20. PubMed ID: 6232913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bromocriptine: effect on serum prolactin and growth hormone in psychogeriatric hospital patients.
    Hontela S; Nair NP; Rosenberg G; Schwartz G; Guyda H
    J Am Geriatr Soc; 1978 Feb; 26(2):49-52. PubMed ID: 627685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EMD 23,448: effects of a putative dopamine autoreceptor agonist in chorea.
    Newman RP; Tamminga CA; Chase TN; LeWitt PA
    J Neural Transm; 1985; 61(1-2):125-9. PubMed ID: 3156964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of a long-acting bromocriptine preparation (Parlodel LA) and its effect on release of prolactin and growth hormone.
    del Pozo E; Schlüter K; Nüesch E; Rosenthaler J; Kerp L
    Eur J Clin Pharmacol; 1986; 29(5):615-8. PubMed ID: 3956565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence for endogenous dopaminergic control of GH release in man.
    Hanew K; Sasaki A; Yoshinaga K
    Tohoku J Exp Med; 1981 Sep; 135(1):103-8. PubMed ID: 7324044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.